# Shanghai MicroPort Medical (Group) Co., Ltd.

Organization · id `cardio:org-shanghai-microport-medical-group-co-ltd` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=Shanghai+MicroPort+Medical+%28Group%29+Co.%2C+Ltd.>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 9 trials in this atlas.

## Technical summary

Sponsor class industry. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: Shanghai MicroPort Medical (Group) Co., Ltd.
- Sponsor class: INDUSTRY

## Connected pages

- Sponsors: Randomized MicroPort's Firehawk DES Versus Xience V: TARGET I Trial (`cardio:ct-nct01196819`)
- Sponsors: Observational Registry Study: FIREHAWK DES for Treating Coronary Artery Disease (CAD) (`cardio:ct-nct01412164`)
- Sponsors: Non-inferiority Study Comparing Firehawk Stent With Abbott Xience Family Stent (TARGET-AC) (`cardio:ct-nct02520180`)
- Sponsors: A Trial of Firesorb in Patients With Coronary Artery Disease: FUTURE-II (`cardio:ct-nct02890160`)
- Sponsors: Trial for MicroPort's Firesorb BVS: FUTURE-III (`cardio:ct-nct03660202`)
- Sponsors: Using Left Atrium Appendage Closure in NVAF Patients With High Risk of Ischemic Stroke (`cardio:ct-nct04479722`)
- Sponsors: Firehawk Rapamycin Target Eluting Coronary Stent North American Trial (`cardio:ct-nct04562532`)
- Sponsors: TARGET-PREMIER Trail in Evaluating the Safety and Efficacy of the Rapamycin Target Eluting Stent in CAS Treatment (`cardio:ct-nct04951050`)
- Sponsors: A Trial of DCB vs DES in the Treatment of de Novo Large Diameter Coronary Atherosclerotic Stenosis(LARGE ONE) (`cardio:ct-nct05961787`)

## Provenance

Content hash: c86daea0fa64e16dc6c244fdf4f3f647dddde441ff5a0de3e4ae26fb374b2be1
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
